GA²LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
We are delighted to share that the “GA²LEN ANACARE consensus statement: Potential of omalizumab in food allergy management”, published in Clinical and Translational Allergy, on behalf … Read more